Frequency of Hsa-miR9 aberrant methylation in metastatic breast cancers

被引：0
|
作者：
Parrella, Paola
Florescu, Anca
Copetti, Massimiliano
Murgo, Roberto
Valori, Vanna Maria
Castelvetere, Marina
Latiano, Tiziana Pia
D'Addetta, Carmela
Fazio, Vito Michele
Maiello, Evaristo
机构：
[1] IRCCS Casa Sollievo Sofferenza, San Giovanni Rotondo, Italy
[2] Univ Al Cuza, Iasi, Romania
[3] IRCCS Casa Sollievo Sofferenza, Med Oncol, San Giovanni Rotondo, Italy
[4] IRCCS Casa Sollievo Sofferenza, Lab Oncol, San Giovanni Rotondo, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21092
引用
收藏
页数：1
相关论文
共 44 条
  • [1] Aberrant methylation of CpG islands in human breast cancers.
    Miyamoto, K.
    Koseki, M.
    Hatanaka, N.
    Kamiike, W.
    Taniyama, K.
    Ushijima, T.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S249 - S250
  • [2] Hsa-miR-9 methylation status is associated with cancer development and metastatic recurrence in patients with clear cell renal cell carcinoma
    Hildebrandt, M. A. T.
    Gu, J.
    Lin, J.
    Ye, Y.
    Tan, W.
    Tamboli, P.
    Wood, C. G.
    Wu, X.
    ONCOGENE, 2010, 29 (42) : 5724 - 5728
  • [3] Hsa-miR-9 methylation status is associated with cancer development and metastatic recurrence in patients with clear cell renal cell carcinoma
    M A T Hildebrandt
    J Gu
    J Lin
    Y Ye
    W Tan
    P Tamboli
    C G Wood
    X Wu
    Oncogene, 2010, 29 : 5724 - 5728
  • [4] Aberrant expression of miR-9 in benign and malignant breast tumors
    Hasanzadeh, Aisan
    Tanha, Hamzeh Mesrian
    Ghaedi, Kamran
    Madani, Mahboobeh
    MOLECULAR AND CELLULAR PROBES, 2016, 30 (05) : 279 - 284
  • [5] Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer
    Lehmann, U.
    Hasemeier, B.
    Christgen, M.
    Mueller, M.
    Roemermann, D.
    Laenger, F.
    Kreipe, H.
    JOURNAL OF PATHOLOGY, 2008, 214 (01): : 17 - 24
  • [6] Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers
    Yuan, JH
    Luo, RZ
    Fujii, S
    Wang, L
    Hu, W
    Andreeff, M
    Pan, Y
    Kadota, M
    Oshimura, M
    Sahin, AA
    Issa, JP
    Bast, RC
    Yu, YH
    CANCER RESEARCH, 2003, 63 (14) : 4174 - 4180
  • [7] Aberrant methylation of p57KIP2 gene in lung and breast cancers and malignant mesotheliomas
    Kobatake, T
    Yano, M
    Toyooka, S
    Tsukuda, K
    Dote, H
    Kikuchi, T
    Toyota, M
    Ouchida, M
    Aoe, M
    Date, H
    Pass, HI
    Doihara, H
    Shimizu, N
    ONCOLOGY REPORTS, 2004, 12 (05) : 1087 - 1092
  • [8] The frequency of methylation of the NT5E gene in metastatic breast cancer
    Lo Nigro, C.
    Lattanzio, L.
    Monteverde, M.
    Syed, N.
    Thompson, A. M.
    Garrone, O.
    Cavicchioli, F.
    Tonissi, F.
    Comino, A.
    McHugh, A.
    Roncaroli, F.
    Palmieri, C.
    Schmid, P.
    Merlano, M. C.
    Crook, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [9] Impact of aberrant methylation of microRNA-9 family members on non-small cell lung cancers
    Muraoka, Takayuki
    Soh, Junichi
    Toyooka, Shinichi
    Maki, Yuho
    Shien, Kazuhiko
    Furukawa, Masashi
    Ueno, Tsuyoshi
    Tanaka, Norimitsu
    Yamamoto, Hiromasa
    Asano, Hiroaki
    Tsukuda, Kazunori
    Miyoshi, Shinichiro
    MOLECULAR AND CLINICAL ONCOLOGY, 2013, 1 (01) : 185 - 189
  • [10] MiR-9-3 and miR-193a are targets for DNA methylation in non-small cell lung cancers
    Heller, Gerwin
    Weinzierl, Marlene
    Noll, Christian
    Babinsky, Valerie
    Ziegler, Barbara
    Altenberger, Corinna
    Minichsdorfer, Christoph
    Lang, Gyoergy
    Doeme, Balazs
    End-Pfuetzenreuter, Adelheid
    Arns, Britt-Madeleine
    Grin, Yuliya
    Klepetko, Walter
    Zielinski, Christoph C.
    Zoechbauer-Mueller, Sabine
    CANCER RESEARCH, 2012, 72
12345